Acoustic biosensor technology company Akubio announced this week the appointment of Andrew Carr as executive chairman of its board of directors. Carr succeeds John Padfield, who has chosen to leave his post as non-executive chairman in order to “focus on other business commitments.”
Over the past 18 years, Carr has worked as director and CEO of Amersham Biosciences.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
